Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$864M |
| 2 |
Shopify
SHOP
|
+$624M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$502M |
| 4 |
TSMC
TSM
|
+$470M |
| 5 |
Constellation Energy
CEG
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$843M |
| 3 |
Broadcom
AVGO
|
+$764M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Uber
UBER
|
+$520M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Communication Services | 17.48% |
| 3 | Consumer Discretionary | 14.75% |
| 4 | Healthcare | 9.68% |
| 5 | Financials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHRT
576
AH Realty Trust
AHRT
$488M
| – | – |
-86,117
| Closed | -$647K |
|
577
Ally Financial
ALLY
$12.8B
| – | – |
-1,064,504
| Closed | -$38.8M |
|
578
Advanced Micro Devices
AMD
$760B
| – | – |
-3,558
| Closed | -$366K |
|
579
Abercrombie & Fitch
ANF
$6.59B
| – | – |
-7,764
| Closed | -$593K |
|
580
ASE Group
ASX
$98.4B
| – | – |
-308,499
| Closed | -$2.7M |
|
581
AtriCure
ATRC
$2.47B
| – | – |
-593,270
| Closed | -$19.1M |
|
|
AVB
582
DELISTED
AvalonBay Communities
AVB
| – | – |
-124,096
| Closed | -$26.6M |
|
583
Biohaven
BHVN
$2.33B
| – | – |
-18,741
| Closed | -$451K |
|
584
Bilibili
BILI
$6.95B
| – | – |
-2,208,581
| Closed | -$42.2M |
|
585
BJs Wholesale Club
BJ
$11.4B
| – | – |
-245,663
| Closed | -$28M |
|
586
Bankunited
BKU
$3.3B
| – | – |
-331,677
| Closed | -$11.4M |
|
|
BPMC
587
DELISTED
Blueprint Medicines
BPMC
| – | – |
-348,817
| Closed | -$30.9M |
|
|
BRDG
588
DELISTED
Bridge Investment Group
BRDG
| – | – |
-1,471,795
| Closed | -$14.1M |
|
589
Cardinal Health
CAH
$54.6B
| – | – |
-254,817
| Closed | -$35.1M |
|
590
CBIZ
CBZ
$2.96B
| – | – |
-6,396
| Closed | -$485K |
|
591
CF Industries
CF
$19B
| – | – |
-48,681
| Closed | -$3.8M |
|
592
Cellebrite
CLBT
$3.01B
| – | – |
-33,184
| Closed | -$645K |
|
593
Cinemark Holdings
CNK
$4.17B
| – | – |
-31,714
| Closed | -$789K |
|
594
Compass
COMP
$8.42B
| – | – |
-58,753
| Closed | -$513K |
|
595
Capri Holdings
CPRI
$1.53B
| – | – |
-889,964
| Closed | -$17.6M |
|
596
California Resources
CRC
$4.64B
| – | – |
-242,343
| Closed | -$10.7M |
|
597
Cytokinetics
CYTK
$10B
| – | – |
-673,932
| Closed | -$27.1M |
|
598
Dow Inc
DOW
$22B
| – | – |
-136,464
| Closed | -$4.77M |
|
|
DX
599
Dynex Capital
DX
$3.2B
| – | – |
-135,515
| Closed | -$1.76M |
|
600
e.l.f. Beauty
ELF
$6.14B
| – | – |
-314,768
| Closed | -$19.8M |
|
Similar funds
Jennison Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Jennison Associates held 642 positions worth $169B, up 18% from $143B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates's Q2 2025 filing shows 75 new, 257 increased, 235 reduced and 68 closed positions. Its largest new stake was Thermo Fisher Scientific: 165,992 shares worth $67.3M. The largest sale was Netflix, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Jennison Associates's largest Q2 2025 buy was Thermo Fisher Scientific: 165,992 shares worth $67.3M.
- Jennison Associates added most to Microsoft in Q2 2025, an estimated $864M increase.
- Jennison Associates's biggest Q2 2025 reduction was Netflix, cutting an estimated $1.03B.
- Jennison Associates fully exited Vertiv in Q2 2025, selling an estimated $308M.
- Jennison Associates's ten largest holdings make up 45% of its $169B portfolio in Q2 2025.
- Jennison Associates opened 75 new positions and closed 68 in Q2 2025.
- Jennison Associates's portfolio value rose 18% quarter-over-quarter to $169B.
Based on Jennison Associates's 13F filing for Q2 2025, filed 1 Aug 2025.